Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D05PFS
|
|||
| Drug Name |
LTI-291
|
|||
| Synonyms |
HZILSILAELSWKN-UHFFFAOYSA-N; 1919820-28-2; SCHEMBL17739965; SCHEMBL19024862; EX-A2518; BCP25413; HY-104038; CS-0026754; 5,7-dimethyl-N-((1r,4r)-4-(pentyloxy)cyclohexyl)pyrazolo[1,5-a]pyrimidine-3-carboxamide
Click to Show/Hide
|
|||
| Indication | Parkinson disease [ICD-11: 8A00.0; ICD-9: 332] | Phase 2 | [1] | |
| Company |
Allergan Parsippany, NJ Lysomal Therapeutics Cambridge, MA
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C20H30N4O2
|
|||
| Canonical SMILES |
CCCCCOC1CCC(CC1)NC(=O)C2=C3N=C(C=C(N3N=C2)C)C
|
|||
| InChI |
1S/C20H30N4O2/c1-4-5-6-11-26-17-9-7-16(8-10-17)23-20(25)18-13-21-24-15(3)12-14(2)22-19(18)24/h12-13,16-17H,4-11H2,1-3H3,(H,23,25)
|
|||
| InChIKey |
HZILSILAELSWKN-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.